Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Biologics and drug delivery revenue17.31M55.14%
Neurosurgery navigation and therapy10.29M32.77%
Capital equipment and software revenue3.8M12.09%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States31.39M100.00%